FAI Advisors, Inc. has filed its Form 13F-HR, disclosing the firm's equity securities portfolio as of the close of business on June 30, 2025. The filing lists the firm's principal business address as 27500 Drake Rd. Suite 110 in Farmington Hills, Michigan. The report was signed by Christopher Cousins, the firm's Chief Compliance Officer.
The filing details a portfolio consisting of 391 equity securities. The largest positions in the portfolio include shares of Berkshire Hathaway Inc. Class B New, Microsoft Corporation, and Eli Lilly & Co. Berkshire Hathaway holds 2,218,026 shares, while Microsoft holds 2,927,755 shares. Eli Lilly & Co. is reported to hold 570,616 shares.
The portfolio also includes significant positions in other major technology and healthcare companies. Advanced Micro Devices Inc. is listed with 220,087 shares, Alphabet Inc. Class C shares with 881,983 shares, and Amazon.com Inc. with 1,554,159 shares. In the healthcare sector, AbbVie Inc. is reported to hold 277,316 shares, and Johnson & Johnson holds 210,184 shares.
The filing also includes various exchange-traded funds (ETFs) and other investment products. Notable ETF holdings include Innovator ETFs Trust US Equity Ultra B, Innovator ETFs Trust US Equity Power Buffer, and iShares Tr Core MSCI EAFE. The filing does not provide a total value for the portfolio.
